Preclinical Imaging In-VIVO Systems and Reagents Market to Exceed US $ 960 Million by 2022

New York, May 05: Market Research Engine has published a new report titled as “Preclinical Imaging In-VIVO Systems And Reagents Market By Modality Analysis; By Reagents Analysis and By Regional Analysis – Global Forecast by 2016 - 2022”

How Big is the Global Preclinical Imaging In-VIVO Systems And Reagents Market?

The preclinical imaging in vivo systems and reagents Market is expected to exceed more than US $ 960 million by 2022 and will grow at a CAGR of more than 6% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/preclinical-imaging-in-vivo-systems-and-reagents-market

Preclinical imaging is the visualization of residing animals for studies purposes, which include drug development. Imaging modalities have long been critical to the researcher in observing modifications, both at the organ, tissue, mobile, or molecular level, in animals responding to physiological or environmental modifications. Imaging modalities which are non-invasive and In-VIVO have turn out to be particularly critical to take a look at animal fashions longitudinally. These imaging systems may be labeled into commonly morphological/anatomical and commonly molecular imaging techniques. Strategies along with high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are normally used for anatomical imaging. Whilst optical imaging (fluorescence and bioluminescence), positron emission tomography (puppy), and single photon emission computed tomography (SPECT) are typically used for molecular visualizations.

The major driving factors of Global Preclinical Imaging IN-VIVO Systems and Reagents Market are as follows:

• Technical advancements in the area of molecular imaging
• Growing market demand for noninvasive small animal imaging techniques
• Increasing number of public and private initiative and financial support to support preclinical researches

The restraining factors of Global Preclinical Imaging In-VIVO Systems and Reagents Market are as follows:

• Strict rules leading preclinical research
• Major installation and operational cost related with preclinical

The Global Preclinical Imaging In-VIVO Systems and Reagents Market is segmented on the lines of its modality, reagents and regional. Based on modality segmentation it covers optical imaging systems, standalone fluorescence imaging systems, bioluminescence/fluorescence imaging systems, optical + X-Ray/optical + CT, micro-PET systems, preclinical nuclear imaging systems, micro-MRI systems, trimodality (SPECT/PET/CT) systems, micro-SPECT systems Micro-CT systems, micro-ultrasound systems, preclinical magnetic particle imaging (MPI) systems and preclinical photo acoustic imaging systems. Under reagents segmentation it covers preclinical optical imaging reagents, fluorescent imaging reagents, bioluminescent imaging reagents, preclinical nuclear imaging reagents, preclinical SPECT probes, preclinical MRI contrast agents, preclinical PET tracers, gadolinium-based preclinical MRI contrast agents, manganese-based preclinical MRI contrast agents, iron-based preclinical MRI contrast agents, preclinical CT contrast agents, barium-based preclinical CT contrast agents, preclinical ultrasound contrast agents, gold nano particles, iodine-based preclinical CT contrast agents and gastrografin-based preclinical CT contrast agents. The Global Preclinical Imaging In-VIVO Systems and Reagents market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for Global Preclinical Imaging In-VIVO Systems and Reagents Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Preclinical Imaging in Vivo Systems and Reagents Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for Global Preclinical Imaging In-VIVO Systems and Reagents Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Aspect Imaging Ltd, Bruker Corporation, Fujifilm Holdings Corporation, Li-Cor Biosciences, MR Solutions Ltd., Mediso Ltd., Milabs B.V., MiltenyiBiotec GmbH, Perkinelmer and Trifoil Imaging. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Global Preclinical Imaging In-VIVO Systems and Reagents Market has been segmented as below:

By Modality Analysis

• Optical Imaging Systems
• Standalone Fluorescence Imaging Systems
• Bioluminescence/Fluorescence Imaging Systems
• Optical + X-Ray/Optical + CT
• Micro-PET Systems
• Preclinical Nuclear Imaging Systems
• Micro-MRI Systems
• Trimodality (SPECT/PET/CT) Systems
• Micro-SPECT Systems Micro-CT Systems
• Micro-Ultrasound Systems
• Preclinical Magnetic Particle Imaging (MPI) Systems
• Preclinical Photo acoustic Imaging Systems

By Reagents Analysis

• Preclinical Optical Imaging Reagents
• Fluorescent Imaging Reagents
• Bioluminescent Imaging Reagents
• Preclinical Nuclear Imaging Reagents
• Preclinical SPECT Probes
• Preclinical MRI Contrast Agents
• Preclinical PET Tracers
• Gadolinium-based Preclinical MRI Contrast Agents
• Manganese-based Preclinical MRI Contrast Agents
• Iron-based Preclinical MRI Contrast Agents
• Preclinical CT Contrast Agents
• Barium-based Preclinical CT Contrast Agents
• Preclinical Ultrasound Contrast Agents
• Gold Nano particles
• Iodine-based Preclinical CT Contrast Agents
• Gastrografin-based Preclinical CT Contrast Agents

By Regional Analysis

• North America
• Europe
• Asia-Pacific
• Rest of the World

Reasons to Buy this Report:

1) Obtain the most up to date information available on all Global Preclinical Imaging In-VIVO Systems and Reagents Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Preclinical Imaging In-VIVO Systems and Reagents Market data.
4) Assess your competitor’s refining portfolio and its evolution.

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.